Farmakeio AR LLC

United States of America

Back to Profile

1-4 of 4 for Farmakeio AR LLC Sort by
Query
Aggregations
Date
2021 1
Before 2020 3
IPC Class
A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles 4
A61K 31/4439 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole 4
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca 3
A61K 47/38 - CelluloseDerivatives thereof 3
A61K 9/16 - AgglomeratesGranulatesMicrobeadlets 3
See more
Found results for  patents

1.

Drug compositions

      
Application Number 16770009
Grant Number 11564910
Status In Force
Filing Date 2018-12-07
First Publication Date 2021-07-08
Grant Date 2023-01-31
Owner FARMAKEIO AR LLC (USA)
Inventor
  • Sutherland, David Clayton
  • Zorn, James Kyle
  • Carlo, Dennis J.

Abstract

Described herein are pharmaceutical compositions including omeprazole and a benzimidazole drug. In some embodiments, the compositions can be formulated for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

IPC Classes  ?

  • A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
  • A61K 31/427 - Thiazoles not condensed and containing further heterocyclic rings
  • A61K 31/4439 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

2.

Drug compositions

      
Application Number 16560806
Grant Number 11045450
Status In Force
Filing Date 2019-09-04
First Publication Date 2019-12-26
Grant Date 2021-06-29
Owner FARMAKEIO AR LLC (USA)
Inventor
  • Sutherland, David Clayton
  • Zorn, James Kyle
  • Carlo, Dennis J.

Abstract

Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

IPC Classes  ?

  • A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 31/4439 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 47/38 - CelluloseDerivatives thereof
  • A61K 9/10 - DispersionsEmulsions
  • A61K 9/14 - Particulate form, e.g. powders
  • C08L 1/28 - Alkyl ethers
  • C01D 5/14 - Preparation of sulfites
  • C01D 7/10 - Preparation of bicarbonates from carbonates
  • C08B 3/06 - Cellulose acetate

3.

Drug compositions

      
Application Number 15914804
Grant Number 10441575
Status In Force
Filing Date 2018-03-07
First Publication Date 2018-07-12
Grant Date 2019-10-15
Owner FARMAKEIO AR LLC (USA)
Inventor
  • Sutherland, David Clayton
  • Zorn, James Kyle
  • Carlo, Dennis J.

Abstract

Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

IPC Classes  ?

  • A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 47/38 - CelluloseDerivatives thereof
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 31/4439 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
  • A61K 9/10 - DispersionsEmulsions
  • A61K 9/14 - Particulate form, e.g. powders
  • C01D 5/14 - Preparation of sulfites
  • C01D 7/10 - Preparation of bicarbonates from carbonates
  • C08B 3/06 - Cellulose acetate
  • C08L 1/28 - Alkyl ethers

4.

Drug compositions comprising an anti-parasitic and proton pump inhibitor

      
Application Number 15675435
Grant Number 10137111
Status In Force
Filing Date 2017-08-11
First Publication Date 2018-02-15
Grant Date 2018-11-27
Owner FARMAKEIO AR LLC (USA)
Inventor
  • Sutherland, David Clayton
  • Zorn, James Kyle
  • Carlo, Dennis J.

Abstract

Described herein are pharmaceutical compositions including a proton pump inhibitor and an antiparasitic drug. In some embodiments, the compositions can be formulated as a non-solid for oral administration. The compositions can be used to treat gastrointestinal conditions. Methods of treatment using the compositions are also described.

IPC Classes  ?

  • A61K 31/4184 - 1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
  • A61K 47/38 - CelluloseDerivatives thereof
  • A61K 9/16 - AgglomeratesGranulatesMicrobeadlets
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 31/4439 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
  • C01D 5/14 - Preparation of sulfites
  • C01D 7/10 - Preparation of bicarbonates from carbonates
  • C08B 3/06 - Cellulose acetate